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Abstract
Background Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by impaired exercise
capacity due to shortness of breath and/or fatigue. Assessment of diastolic dysfunction at rest and with exercise may provide
insight into the pathophysiology of exercise intolerance in HFpEF.
Aims To measure echocardio-Doppler-derived parameters of diastolic function as they relate to various indices of aerobic
exercise capacity in HFpEF.
Methods We selected 16 subjects with clinically stable HFpEF, no evidence of volume overload, but impaired functional
capacity by cardiopulmonary exercise testing [peak oxygen consumption (VO2)]. We measured the transmitral E and A flow
velocities, E/A ratio, and E deceleration time (DT) and tissue Doppler E0 velocity. We also indexed the E0 to the DT, as additional
measure of impaired relaxation (E0 DT), and calculated the diastolic functional reserve index (DFRI), as the product of E0 at rest
and change in E0 with exercise.
Results E0 velocity, at rest and peak exercise, as well as the DFRI positively correlated with peak VO2, whereas DT, E0 DT, and
E/E0 with exercise inversely correlated with peak VO2. Of note, the E0 DT at rest also signiﬁcantly predicted E0 velocity at peak
exercise (R = +0.81, P < 0.001). Exercise E0 was the only independent predictor of peak VO2 at multivariable analysis (R = +0.67,
P = 0.005).
Conclusions The E0 velocity at peak exercise is a strong and independent predictor of aerobic exercise capacity as measured
by peak VO2 in patients with HFpEF, providing the link between abnormal myocardial relaxation with exercise and impaired
aerobic exercise capacity in HFpEF.
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Background
Heart failure with preserved ejection fraction (HFpEF) is a
heterogeneous clinical syndrome characterized by impaired
cardiac function, mainly diastolic, that induces exertionlimiting shortness of breath and fatigue.1 Abnormalities
in the echocardio-Doppler derived parameters of diastolic
function are present in patients with HFpEF and are part

of the European Society of Cardiology recommended diagnostic criteria.2 One such parameter, the early diastolic mitral annular velocity (E0 ), reﬂects the elastic recoil and the
early active phase of relaxation during diastole.3 Assessment of myocardial relaxation, however, is limited if completed only at rest, as the initiation or signiﬁcant
worsening in symptoms occurs primarily with physical
exertion.

© 2017 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
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Aims
The aim of this study was to measure myocardial relaxation
using the E0 velocity at rest and peak exercise in patients with
symptomatic HFpEF limited by shortness of breath and/or fatigue, as it relates to various indices of aerobic exercise capacity, and to other echocardio-Doppler derived parameters
of systolic and diastolic function.

Methods
We selected 16 subjects with symptomatic HFpEF [New York
Heart Association (NYHA) functional class II–III] who showed
impaired functional capacity due to shortness of breath or fatigue. Heart failure with preserved ejection fraction was diagnosed on the basis of clinical, Doppler echocardiography,
laboratory, and/or hemodynamic data according to the
European Society of Cardiology recommendations.2 Patients
with moderate–severe valvular heart disease, pericardial
disease, restrictive cardiomyopathy, pulmonary artery hypertension (group I), atrial ﬁbrillation, obstructive pulmonary disease, anaemia (haemoglobin <11 g/dL or ferritin <100 μg/L),
or mechanical limitation to exertion due to musculoskeletal
or neurologic disease were excluded.
We measured Doppler echocardiography parameters of
systolic and diastolic function, including left ventricular enddiastolic and end-systolic volumes, stroke volume, ejection
fraction (LVEF), transmitral ﬂow velocities [E, A, E/A ratio,
and E wave deceleration time (DT)], tissue Doppler-derived
early diastolic mitral annular velocity (E0 ), and longitudinal
systolic strain (S0 ) measured at tissue Doppler averaged
between lateral and septal according to the American Society
of Echocardiography recommendations.4 We also indexed
the E0 velocity by the DT to obtain a measure (E0 DT) that
reﬂected both the delay in relaxation (DT) and the peak velocity in diastolic ﬁlling (E0 ). A higher E0 and shorter DT would
reﬂect better myocardial relaxation, whereas reduced E0 or
prolonged DT would each reﬂect impaired relaxation with
an additive value. E, E0 and E/E0 ratio were also measured
at peak exercise by having the patient sit down immediately
after interruption of the exertion and obtaining an apical
view within 1 min. The interval change in E0 and E/E0 were calculated (ΔE0 exercise and ΔE/E0 exercise, respectively), as was the
diastolic functional reserve index (DFRI), deﬁned as the product of E0 rest•ΔE0 exercise.5 Subjects were also asked to complete
the Duke Activity Status Index (DASI) and the Minnesota Living With Heart Failure (MLWHF) questionnaires to estimate
functional capacity.
Cardiopulmonary exercise testing (CPX) was performed
using a metabolic cart that interfaced with a treadmill using
a conservative ramping protocol according to the American
Heart Association recommendations,6 as previously described
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by our group.7 Expired gases were sampled using a
mouthpiece-mounted sensor and were analysed to continuously measure oxygen (O2) uptake. The highest 10 s interval
average value within the ﬁnal 30 s of exercise was used to deﬁne peak oxygen consumption (VO2) and expressed as (i) an
absolute value (mL/kg); (ii) an indexed by body weight (mL/
kg/min); and (iii) a percent (%) of predicted values according
to age, gender, and ideal body weight. Subjects in whom exertion was limited by angina (with or without ECG changes),
uncontrolled hypertension, or arrhythmias were excluded.
Data were reported as median and interquartile range.
Correlations between two variables were analysed using the
Spearman correlation test. Multivariable linear regression
analysis with a stepwise approach was used to assess for collinearity and associations between the dependent and independent variables.

Results
Table 1 shows the demographic characteristics of the
subjects. Twelve (75%) were women; median age was 55
Table 1 Characteristics of the subjects
Age, years
Sex, male/female
Race, Caucasian/African–American
2
Body mass index (kg/m )
Arterial hypertension
Diabetes mellitus
NT-proBNP (ng/mL)
NYHA functional class, II/III
DASI score
MLWHF score
Echocardio-Doppler parameters
Left ventricular ejection fraction, %
Stroke volume, mL
Longitudinal strain (tissue Doppler), cm/s
E0 velocity, cm/s
E/E0 ratio
E/A ratio
DT, ms
E0 indexed by DT (E0 DT)
Exercise E0 velocity, cm/s
Exercise E/E0
Diastolic functional reserve index (DFRI)
Functional capacity
Exercise time, min
Respiratory exchange ratio
Peak oxygen consumption (VO2), mL/min
Peak oxygen consumption (VO2),
mL/kg/min
Peak oxygen consumption (VO2),
mL/kg/min; % predicted

55 (51–60)
4 (25%)/12 (75%)
7 (44%)/9 (56%)
41 (37–46)
13 (81%)
11 (69%)
174 (70–308)
7 (44%)/9 (56%)
21.4 (11.4–31.3)
66.5 (45.5–74.5)
60 (57–65)
69 (58–74)
7.9 (6.9–8.1)
6.9 (5.2–9.1)
10.7 (8.6–15.1)
1.1 (0.9–1.5)
230 (192–288)
0.034 (0.021–0.047)
10.1 (8.2–12.5)
10.7 (8.0–12.5)
18.5 (9.2–31.3)
8.2 (7.0–9.7)
1.09 (1.04–1.13)
1,742 (1,534–2,193)
15.8 (13.5–17.9)
57 (46–72)

DASI, Duke Activity Status Index; DFRI: Diastolic functional reserve
index; DT, Deceleration time of the early ﬁlling at transmitral ﬂow
pulsed waved Doppler; E, Early velocity of transmitral ﬂow at
pulsed wave Doppler; E0 , Early velocity of the mitral annulus at
pulsed wave tissue Doppler; MLWHF, Minnesota Living with Heart
Failure; NT-proBNP, N-terminal pro-Brain Natriuretic Peptide;
NYHA, New York Heart Association; Peak VO2, peak oxygen consumption at cardiopulmonary exercise testing.
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Figure 1 Correlation between echocardio-Doppler derived measures of impaired myocardial relaxation and aerobic exercise capacity in patients with
heart failure and preserved ejection fraction.

(51–60) years. The duration of exercise was 8.5 min
(6.6–10.6) with a peak VO2 of 14.0 (12.0–18.7) mL/kg/min.
LVEF was 60% (57–65).
Median E0 at rest and peak exercise were 6.9 cm/s
(5.2–9.1) and 10.1 cm/s (8.2–12.5) (P = 0.001 for the change),
respectively, whereas the E/E0 ratio at rest and peak exercise
were 10.7 (8.6–15.1) and 10.7 (8.0–12.5) (P = 0.28),
respectively.
E0 velocity, at rest and at peak exercise, and the DFRI
(=E0 rest •ΔE0 exercise) positively correlated with exercise time
and peak VO2 expressed in relative (mL/kg/min), absolute
(mL/min), and percent (%) of predicted values (Figure 1),
whereas exercise E/E0 was inversely correlated with exercise
time (R = 0.51, P = 0.042) and peak VO2 (R = 0.45, P = 0.079).
While both E0 velocity at rest and E wave DT at rest significantly correlated with peak VO2 (R = +0.52, P = 0.040 and
R = 0.50, P = 0.048, inversely), the E0 velocity indexed by
DT (E0 DT) at rest more strongly correlated with peak VO2
(R = +0.62, P = 0.010).
We found no statistically signiﬁcant association between
end-diastolic or end-systolic volumes, stroke volume, ejection
fraction, or longitudinal systolic strain at tissue Doppler and
exercise time or peak VO2 (all P > 0.30).
A multivariable analysis that included E/A, DT, E0 , E0 DT, E/E0
at rest, E0 and E/E0 with exercise, ΔE0 exercise, ΔE/E0 exercise, and

DFRI found exercise E0 was the only independent predictor of
peak VO2 (P = 0.005)—such analysis, however, may be limited
by collinearity and should be considered as explorative only.
Of note, E0 velocity (R = +0.71, P = 0.002), DT (R = 0.56,
P = 0.023), and, even more strongly, E0 DT (R = +0.81,
P < 0.001) at rest predicted exercise E0 (Figure 1).

Conclusions
Impaired diastolic reserve, measured as an inadequate
increase in myocardial relaxation, is considered a hallmark
of HFpEF and is associated with a progressive decline in
exercise capacity.1,5,8 However, measuring diastolic parameters only at rest may not reveal the severity of limitation in
patients suffering from this syndrome. In the current study,
we found that impaired myocardial relaxation during
exertion, measured with the E0 velocity at peak exercise, is
a strong and independent predictor of aerobic exercise
capacity as measured by peak VO2 in a cohort of relatively
young obese female patients with HFpEF. It has been shown
that E0 correlates with the invasively measured constant of
isovolumetric relaxation time (τ), which is almost universally
abnormal in HFpEF.9 The correlation between E0 and τ is
ESC Heart Failure 2017; 4: 351–355
DOI: 10.1002/ehf2.12147

354

C. Trankle et al.

independent of the left ventricular ﬁlling pressure,10 and E0 is
a strong independent predictor of outcomes,11 thus
representing an ideal marker of myocardial relaxation. In conditions of normal ﬁlling pressures, the E wave DT also linearly
correlates with τ,4,5 and as such, it predicted impaired peak
VO2 in our cohort. Exercise E0 showed the strongest and independent association with peak VO2 at multivariable analysis,
and this is likely related to the fact that the E0 velocity at peak
exercise is dependent upon both the E0 velocity at rest and
the ability to accommodate increased venous return with
exercise. While other studies have shown increased left
ventricular ﬁlling pressures during exercise, this study specifically shows that the impairment in myocardial relaxation,
measured with E0 velocity, is abnormal and drives exercise
intolerance in HFpEF. Measuring E0 velocity at peak exercise
is a challenge considering the potential difﬁculty in obtaining
apical pulsed-wave Doppler recording at peak exercise. In our
data, we ﬁnd that exercise E0 could be predicted by resting E0
and the E wave DT, both independent markers of impaired
relaxation. When indexing E0 by DT, to reﬂect both peak velocity of volume accommodation and the delay in myocardial
relaxation, the E0 DT at rest appeared to be a strong predictor
of exercise E0 . The link between E0 DT at rest and exercise E0
provides both a physiologic explanation of an impairment in
the augmentation of E0 due to a prolonged DT and also a
means to estimate peak VO2 using resting data (i.e. E0 and DT).
Altogether, the predictive behaviour of E0 DT and exercise E0
provides the link between abnormal myocardial relaxation
with exercise and impaired aerobic exercise capacity in patients with HFpEF. This small single study has important limitations that may limit external validity, primarily because it
included mainly moderately-to-severely obese female

patients with controlled hypertension and levels of NT-proBNP
that in many cases would not exceed the proposed cut-off
value for HFpEF, a phenotype that may differ from older
female patients with uncontrolled hypertension and/or severe
left ventricular hypertrophy. Nevertheless, these ﬁndings may
have diagnostic, prognostic, and therapeutic implications.
From a diagnostic standpoint, the association of the diastolic
parameters and in particular of the E0 velocity with impaired
functional capacity reinforces the view that impaired diastolic
function is key phenomenon in this HFpEF subgroup.1,11 The
close association between E0 velocity with exercise, and of
E0 DT, with peak VO2, a well-validated prognostic indicator in
HF,6 supports the concept that the severity of the impaired
myocardial relaxation is an important factor in the pathophysiology of HFpEF. Therefore, therapies that enhance myocardial
relaxation and diastolic functional reserve function may provide a novel approach to improve symptoms of exertional intolerance in a subgroup of patients with HFpEF.
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